A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination. (V419-013)
Status:
Not yet recruiting
Trial end date:
2021-01-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the durability of protection against hepatitis B
virus (HBV) infection approximately 9 years after vaccination with Vaxelis®. This is an
estimation study, and no formal hypothesis testing will be performed.